Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma

被引：3
|
作者：
Krishnan, Jerry A. [1 ]
Au, David H. [2 ,3 ]
机构：
[1] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, 1220 S Wood St,MC 619, Chicago, IL 60608 USA
[2] Vet Affairs Puget Sound Hlth Care Syst, Ctr Innovat Vet Ctr & Value Driven Care, Hlth Serv Res & Dev Serv, Seattle, WA USA
[3] Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 319卷 / 14期
关键词：
D O I：
10.1001/jama.2018.2029
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1441 / 1443
页数：3
相关论文
共 44 条
  • [31] Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma
    Spain, C. Victor
    Dayal, Parul
    Ding, Yingjie
    Iribarren, Carlos
    Omachi, Theodore A.
    Chen, Hubert
    JOURNAL OF ASTHMA, 2022, 59 (06) : 1237 - 1247
  • [32] Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registry
    Gemicioglu, Bilun
    Gokmen, Derya
    Can, Ali
    Sevinc, Can
    Oguzulgen, Ipek Kivilcim
    Soyyigit, Sadan
    Yakut, Tugce
    Havlucu, Yavuz
    Aydin, Omur
    Buhari, Gozde Koycu
    Sozener, Zeynep Celebi
    Bulut, Ismet
    Beyaz, Sengul
    Orcen, Cihan
    Ozdemir, Secil Kepil
    Keren, Metin
    Damadoglu, Ebru
    Kalpaklioglu, Ayse Fusun
    Baccioglu, Ayse
    Yalim, Sumeyra Alan
    Yilmaz, Insu
    Kalkan, Ilkay Koca
    Uysal, Mehmet Atilla
    Niksarlioglu, Elif Yelda Ozgun
    Kalyoncu, Ali Fuat
    Karakaya, Gul
    Erbay, Muge
    Nayci, Sibel
    Tepetam, Fatma Merve
    Gelincik, Asli
    Dirol, Hulya
    Goksel, Ozlem
    Karaoglanoglu, Selen
    Erkekol, Ferda Oner
    Isik, Sacide Rana
    Yildiz, Fusun
    Yavuz, Yasemin
    Karadogan, Dilek
    Bozkurt, Nurgul
    Seker, Ummuhan
    Basyigit, Ilknur
    Baris, Serap Argun
    Ucar, Elif Yilmazel
    Erdogan, Tuba
    Polatli, Mehmet
    Ediger, Dane
    Gunaydin, Fatma Esra
    Turk, Murat
    Pur, Leyla
    Katran, Zeynep Yegin
    RESPIRATORY MEDICINE, 2025, 236
  • [33] Do long-acting β2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD?
    van Schayck, CP
    EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (04) : 631 - 634
  • [34] Cochrane Corner: Addition of Long-Acting Beta2 Agonists or Long-Acting Muscarinic Antagonists Versus Doubling the Dose of Inhaled Corticosteroids (ICS) in Adolescents and Adults With Uncontrolled Asthma With Medium-Dose ICS
    Baigel, Rachel
    Gregory, Ian
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (09): : 647 - 650
  • [35] The role of fixed dose combinations of inhaled cortikosteroids, long acting beta-2 agonists, and long acting muscarinic antagonists (ICS/LABA/LAMA) in the treatment of asthma
    Metan, Esra Unsay
    Bavbek, Sevim
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2021, 69 (03): : 369 - 379
  • [36] Use of Long-Acting Muscarinic Antagonists and Biologic Therapy as Add-On Treatment for Asthma: Real-World Data Analysis Using Insurance Claims from 2012-2017
    Chen, H.
    Ding, Y.
    Spain, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [37] Long-Acting β2-Agonists or Leukotriene Receptor Antagonists as Add-On Therapy to Inhaled Corticosteroids for the Treatment of Persistent Asthma
    Nils Ringdal
    Drugs, 2003, 63 (Suppl 2) : 21 - 33
  • [38] Effects of Inhaled Corticosteroids, Leukotriene Receptor Antagonists, or Both, Plus Long-Acting β2-Agonists on Asthma Pathophysiology: a Review of the Evidence
    A. Maurizio Vignola
    Drugs, 2003, 63 (Suppl 2) : 35 - 51
  • [39] Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis (vol 319, pg 1473, 2018)
    Sobieraj, D. M.
    Baker, W. L.
    Nguyen, E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (18): : 1939 - 1939
  • [40] Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis
    Oba, Yuji
    Anwer, Sumayya
    Patel, Tarang
    Maduke, Tinashe
    Dias, Sofia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (08):
12345